abstract |
The present invention relates to a medicament, therapeutic method, kit, and use for treating cancer in a subject, wherein the VEGF signaling inhibitor and the PD-1/PD-L1 signaling inhibitor are administered in combination as well as the VEGF signaling inhibitor; PD-1/PD-L1 signaling inhibitors, and combinations thereof. |